Predictive factors for work-day loss in Behçet's syndrome : A multi-center study
© 2019 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd..
OBJECTIVE: The aim of this multi-center study was to assess predictive factors for work-day loss as an indirect cost element in Behçet's syndrome (BS).
METHODS: In this cross-sectional, multi-center study, 834 BS patients (F/M: 441/393, age mean: 38.4 ± 10.9 years) were included. Data were collected by a questionnaire regarding treatment protocols, disease duration, smoking pattern, frequency of medical visits during the previous year and self-reported work-day loss during the previous year.
RESULTS: Work-day loss was observed in 16.2% of patients (M/F: 103/32). The percentages of being a smoker (81.8%), using immunosuppressive (IS) medications (82%), and having disease duration <5 years (74%) were higher in male patients with work-day loss (P < .05). The majority of males (90.9%) had more than four clinic visits during the previous year. Moreover, the mean work-day loss (30.8 ± 57.7 days) was higher in patients with vascular involvement (56.1 ± 85.9) than those without (26.4 ± 50.6 days) (P = .046). In addition, increased frequency of ocular involvement (25.9%) was also observed in patients with work-day loss compared to others (8.6%) (P = .059).
CONCLUSION: Work-day loss was associated with both vascular and ocular involvement. Close associations were observed among male gender, early period of the disease, frequent medical visits, being a smoker and treatment with IS medications in patients with work-day loss.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
International journal of rheumatic diseases - 23(2020), 2 vom: 07. Feb., Seite 240-246 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mumcu, Gonca [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Behçet's disease |
|---|
| Anmerkungen: |
Date Completed 16.12.2020 Date Revised 16.12.2020 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/1756-185X.13771 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM304592676 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM304592676 | ||
| 003 | DE-627 | ||
| 005 | 20231225115321.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/1756-185X.13771 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1015.xml |
| 035 | |a (DE-627)NLM304592676 | ||
| 035 | |a (NLM)31858715 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mumcu, Gonca |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Predictive factors for work-day loss in Behçet's syndrome |b A multi-center study |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.12.2020 | ||
| 500 | |a Date Revised 16.12.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2019 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd. | ||
| 520 | |a OBJECTIVE: The aim of this multi-center study was to assess predictive factors for work-day loss as an indirect cost element in Behçet's syndrome (BS) | ||
| 520 | |a METHODS: In this cross-sectional, multi-center study, 834 BS patients (F/M: 441/393, age mean: 38.4 ± 10.9 years) were included. Data were collected by a questionnaire regarding treatment protocols, disease duration, smoking pattern, frequency of medical visits during the previous year and self-reported work-day loss during the previous year | ||
| 520 | |a RESULTS: Work-day loss was observed in 16.2% of patients (M/F: 103/32). The percentages of being a smoker (81.8%), using immunosuppressive (IS) medications (82%), and having disease duration <5 years (74%) were higher in male patients with work-day loss (P < .05). The majority of males (90.9%) had more than four clinic visits during the previous year. Moreover, the mean work-day loss (30.8 ± 57.7 days) was higher in patients with vascular involvement (56.1 ± 85.9) than those without (26.4 ± 50.6 days) (P = .046). In addition, increased frequency of ocular involvement (25.9%) was also observed in patients with work-day loss compared to others (8.6%) (P = .059) | ||
| 520 | |a CONCLUSION: Work-day loss was associated with both vascular and ocular involvement. Close associations were observed among male gender, early period of the disease, frequent medical visits, being a smoker and treatment with IS medications in patients with work-day loss | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Behçet's disease | |
| 650 | 4 | |a ocular involvement | |
| 650 | 4 | |a vascular involvement | |
| 650 | 4 | |a work-day loss | |
| 650 | 7 | |a Immunosuppressive Agents |2 NLM | |
| 700 | 1 | |a Yay, Meral |e verfasserin |4 aut | |
| 700 | 1 | |a Aksoy, Aysun |e verfasserin |4 aut | |
| 700 | 1 | |a Taş, Mehmet Nedim |e verfasserin |4 aut | |
| 700 | 1 | |a Armağan, Berkan |e verfasserin |4 aut | |
| 700 | 1 | |a Sarı, Alper |e verfasserin |4 aut | |
| 700 | 1 | |a Bozca, Burçin Cansu |e verfasserin |4 aut | |
| 700 | 1 | |a Tekgöz, Emre |e verfasserin |4 aut | |
| 700 | 1 | |a Karadağ, Duygu Temiz |e verfasserin |4 aut | |
| 700 | 1 | |a Badak, Suade Özlem |e verfasserin |4 aut | |
| 700 | 1 | |a Tecer, Duygu |e verfasserin |4 aut | |
| 700 | 1 | |a Bes, Cemal |e verfasserin |4 aut | |
| 700 | 1 | |a Şahin, Ali |e verfasserin |4 aut | |
| 700 | 1 | |a Erken, Eren |e verfasserin |4 aut | |
| 700 | 1 | |a Cefle, Ayse |e verfasserin |4 aut | |
| 700 | 1 | |a Çınar, Muhammet |e verfasserin |4 aut | |
| 700 | 1 | |a Yılmaz, Sedat |e verfasserin |4 aut | |
| 700 | 1 | |a Karaçaylı, Ümit |e verfasserin |4 aut | |
| 700 | 1 | |a Alpsoy, Erkan |e verfasserin |4 aut | |
| 700 | 1 | |a Şenel, Soner |e verfasserin |4 aut | |
| 700 | 1 | |a Yaşar Bilge, Şule |e verfasserin |4 aut | |
| 700 | 1 | |a Kaşifoğlu, Timuçin |e verfasserin |4 aut | |
| 700 | 1 | |a Karadağ, Ömer |e verfasserin |4 aut | |
| 700 | 1 | |a Aksu, Kenan |e verfasserin |4 aut | |
| 700 | 1 | |a Keser, Gökhan |e verfasserin |4 aut | |
| 700 | 1 | |a Alibaz-Öner, Fatma |e verfasserin |4 aut | |
| 700 | 1 | |a İnanç, Nevsun |e verfasserin |4 aut | |
| 700 | 1 | |a Ergun, Tülin |e verfasserin |4 aut | |
| 700 | 1 | |a Direskeneli, Haner |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of rheumatic diseases |d 2009 |g 23(2020), 2 vom: 07. Feb., Seite 240-246 |w (DE-627)NLM197180566 |x 1756-185X |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2020 |g number:2 |g day:07 |g month:02 |g pages:240-246 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/1756-185X.13771 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2020 |e 2 |b 07 |c 02 |h 240-246 | ||